Details of the Drug

General Information of Drug (ID: DMTJ139)

Drug Name

Oxazyme

Synonyms

SCHEMBL6508464; BDBM92490; IxC1-62/47; Recombinant oxalate degrading enzyme (oral, hyperoxaluria), OxThera; Recombinant oxalate degrading enzyme (oral, hyperoxaluria), Q-Med/ Ixion Biotechnology

Indication

Disease Entry	ICD 11	Status	REF
Hyperoxaluria	5C51.2	Phase 1/2	[1]

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C14H15BrN4O
Canonical SMILES: CC1=C2C(=NN1)C3=C(C=CC(=C3)Br)N(C2=O)CCCN
InChI: InChI=1S/C14H15BrN4O/c1-8-12-13(18-17-8)10-7-9(15)3-4-11(10)19(14(12)20)6-2-5-16/h3-4,7H,2,5-6,16H2,1H3,(H,17,18)
InChIKey: LLKFNPUXQZHIAE-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 11290583
TTD ID: D0X8SY

References

1	ClinicalTrials.gov (NCT01127087) Oxazyme in Patients With Hyperoxaluria. U.S. National Institutes of Health.